Immunotherapy of Cancer, Volume 143, the latest release in the Advances in Cancer Research series, provides invaluable information on the exciting and fast-moving field of cancer research. Contributions from leading experts in the field make this a must have update on the topic.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Contributors - p. ix 6. Preface - p. xiii 7. Chapter One: Translation of cancer immunotherapy from the bench to the bedside - p. xv 8. Chapter Two: From immune checkpoints to vaccines: The past, present and future of cancer immunotherapy - p. 62 9. Chapter Three: Co-stimulatory and co-inhibitory pathways in cancer immunotherapy - p. 144 10. Chapter Four: Immunometabolism: A new target for improving cancer immunotherapy - p. 194 11. Chapter Five: Impact of the microbiome on cancer progression and response to anti-cancer therapies - p. 253 12. Chapter Six: Immunotherapy in breast cancer: Current status and future directions - p. 294 13. Chapter Seven: Can CpG methylation serve as surrogate markers for immune infiltration in cancer? - p. 349
Immunotherapy of Cancer, Volume 143, the latest release in the Advances in Cancer Research series, provides invaluable information on the exciting and fast-moving field of cancer research. Contributions from leading experts in the field make this a must have update on the topic.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Contributors - p. ix 6. Preface - p. xiii 7. Chapter One: Translation of cancer immunotherapy from the bench to the bedside - p. xv 8. Chapter Two: From immune checkpoints to vaccines: The past, present and future of cancer immunotherapy - p. 62 9. Chapter Three: Co-stimulatory and co-inhibitory pathways in cancer immunotherapy - p. 144 10. Chapter Four: Immunometabolism: A new target for improving cancer immunotherapy - p. 194 11. Chapter Five: Impact of the microbiome on cancer progression and response to anti-cancer therapies - p. 253 12. Chapter Six: Immunotherapy in breast cancer: Current status and future directions - p. 294 13. Chapter Seven: Can CpG methylation serve as surrogate markers for immune infiltration in cancer? - p. 349
